Best TWAS P=1.18e-21 · Best GWAS P=2.74e-20 conditioned to 0.103
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | C6orf164 | 0.06 | 0.01 | blup | 430 | 0.03 | 4.2e-05 | -5.51 | -5.3 | 9.5e-08 | 0.33 | 0.76 | 0.12 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | ZNF292 | 0.04 | 0.05 | lasso | 12 | 0.03 | 4.1e-05 | -9.11 | 9.3 | 2.0e-20 | -1.00 | 0.03 | 0.97 | FALSE |
3 | GTEx | Adipose Subcutaneous | SMIM8 | 0.10 | 0.02 | lasso | 5 | 0.02 | 1.7e-02 | -8.18 | 7.4 | 1.9e-13 | -0.61 | 0.38 | 0.07 | FALSE |
4 | GTEx | Adipose Visceral Omentum | C6orf163 | 0.17 | 0.14 | lasso | 9 | 0.17 | 2.8e-09 | -8.16 | -6.7 | 2.6e-11 | 0.53 | 0.85 | 0.14 | FALSE |
5 | GTEx | Artery Aorta | RP11-393I2.4 | 0.10 | 0.03 | lasso | 5 | 0.02 | 2.4e-02 | -8.85 | 9.0 | 1.8e-19 | -0.84 | 0.10 | 0.82 | FALSE |
6 | GTEx | Artery Coronary | C6orf163 | 0.27 | 0.05 | lasso | 4 | 0.02 | 5.9e-02 | -8.16 | -6.2 | 4.8e-10 | 0.65 | 0.11 | 0.12 | FALSE |
7 | GTEx | Artery Tibial | C6orf163 | 0.12 | 0.08 | lasso | 2 | 0.07 | 7.5e-06 | -8.79 | -8.5 | 1.5e-17 | 0.77 | 0.20 | 0.78 | FALSE |
8 | GTEx | Brain Cortex | SMIM8 | 0.43 | 0.24 | enet | 44 | 0.34 | 4.6e-10 | -4.67 | -5.3 | 1.4e-07 | 0.71 | 0.11 | 0.88 | FALSE |
9 | GTEx | Breast Mammary Tissue | C6orf163 | 0.13 | 0.10 | lasso | 12 | 0.09 | 1.5e-05 | -8.76 | -8.1 | 3.7e-16 | 0.71 | 0.53 | 0.46 | FALSE |
10 | GTEx | Breast Mammary Tissue (Male) | C6orf163 | 0.09 | 0.00 | enet | 4 | 0.01 | 2.2e-01 | -8.41 | -7.0 | 2.1e-12 | 0.61 | 0.07 | 0.19 | FALSE |
11 | GTEx | Breast Mammary Tissue (Female) | C6orf163 | 0.21 | 0.00 | lasso | 4 | 0.03 | 5.3e-02 | -4.07 | -7.2 | 6.4e-13 | 0.59 | 0.06 | 0.17 | FALSE |
12 | GTEx | Cells EBV-transformed lymphocytes | C6orf163 | 0.18 | 0.14 | lasso | 4 | 0.15 | 1.5e-05 | -8.19 | -8.5 | 1.6e-17 | 0.78 | 0.29 | 0.58 | FALSE |
13 | GTEx | Cells Transformed fibroblasts | SMIM8 | 0.18 | 0.14 | lasso | 5 | 0.12 | 1.4e-09 | -8.19 | 8.2 | 2.3e-16 | -0.74 | 0.98 | 0.02 | FALSE |
14 | GTEx | Cells Transformed fibroblasts | C6orf163 | 0.16 | 0.14 | lasso | 3 | 0.18 | 2.7e-13 | -8.16 | -8.5 | 1.8e-17 | 0.74 | 0.60 | 0.40 | FALSE |
15 | GTEx | Colon Sigmoid | RP11-393I2.4 | 0.14 | 0.02 | enet | 27 | 0.07 | 2.0e-03 | -8.85 | 5.8 | 8.8e-09 | -0.60 | 0.04 | 0.79 | FALSE |
16 | GTEx | Esophagus Muscularis | C6orf163 | 0.08 | 0.07 | lasso | 4 | 0.07 | 6.4e-05 | -8.23 | -6.9 | 4.7e-12 | 0.57 | 0.58 | 0.19 | FALSE |
17 | GTEx | Lung | C6orf163 | 0.07 | 0.08 | enet | 7 | 0.09 | 2.8e-07 | -8.16 | -6.8 | 8.0e-12 | 0.55 | 0.65 | 0.23 | FALSE |
18 | GTEx | Lung | RP11-393I2.4 | 0.09 | 0.06 | lasso | 2 | 0.04 | 8.4e-04 | -8.85 | 8.9 | 7.5e-19 | -0.82 | 0.30 | 0.64 | FALSE |
19 | GTEx | Muscle Skeletal | C6orf163 | 0.07 | 0.02 | enet | 32 | 0.04 | 5.5e-05 | -8.47 | -7.0 | 1.9e-12 | 0.53 | 0.12 | 0.87 | FALSE |
20 | GTEx | Nerve Tibial | SMIM8 | 0.22 | 0.10 | lasso | 8 | 0.16 | 3.8e-11 | -8.23 | 5.5 | 3.7e-08 | -0.41 | 0.98 | 0.02 | FALSE |
21 | GTEx | Nerve Tibial | ZNF292 | 0.09 | 0.07 | enet | 16 | 0.10 | 1.5e-07 | 8.60 | 9.6 | 1.2e-21 | -0.89 | 0.09 | 0.91 | TRUE |
22 | GTEx | Nerve Tibial | C6orf163 | 0.12 | 0.06 | enet | 10 | 0.11 | 2.5e-08 | -8.23 | -5.6 | 1.7e-08 | 0.38 | 0.91 | 0.07 | FALSE |
23 | GTEx | Nerve Tibial | RP11-393I2.4 | 0.08 | 0.09 | enet | 18 | 0.09 | 6.8e-07 | -8.41 | 9.2 | 4.5e-20 | -0.84 | 0.22 | 0.78 | FALSE |
24 | GTEx | Pituitary | RP11-393I2.4 | 0.39 | 0.10 | lasso | 12 | 0.10 | 1.6e-03 | -5.40 | 8.0 | 9.6e-16 | -0.70 | 0.09 | 0.37 | FALSE |
25 | GTEx | Stomach | C6orf163 | 0.10 | 0.06 | lasso | 1 | 0.05 | 2.3e-03 | -8.18 | -8.2 | 2.8e-16 | 0.74 | 0.30 | 0.18 | FALSE |
26 | GTEx | Thyroid | C6orf163 | 0.21 | 0.08 | enet | 32 | 0.14 | 6.6e-11 | -8.23 | -5.5 | 2.9e-08 | 0.37 | 0.85 | 0.15 | FALSE |
27 | GTEx | Vagina | C6orf163 | 0.28 | 0.13 | enet | 28 | 0.18 | 5.7e-05 | -8.23 | -5.8 | 8.0e-09 | 0.59 | 0.19 | 0.36 | FALSE |
28 | GTEx | Whole Blood | C6orf163 | 0.09 | 0.04 | enet | 14 | 0.02 | 6.4e-03 | -0.68 | -5.6 | 2.5e-08 | 0.16 | 0.12 | 0.14 | FALSE |
29 | METSIM | Adipose | C6orf164 | 0.05 | 0.06 | lasso | 8 | 0.06 | 9.3e-10 | -8.12 | -8.4 | 5.6e-17 | 0.79 | 0.87 | 0.13 | FALSE |
30 | METSIM | Adipose | C6ORF165 | 0.03 | 0.04 | lasso | 4 | 0.03 | 7.7e-06 | -5.25 | -5.6 | 2.3e-08 | 0.54 | 0.95 | 0.04 | FALSE |
31 | NTR | Blood | C6orf162 | 0.02 | 0.02 | blup | 411 | 0.02 | 1.7e-08 | 8.62 | -8.0 | 1.3e-15 | 0.86 | 0.09 | 0.91 | FALSE |
32 | NTR | Blood | SLC35A1 | 0.02 | 0.00 | bslmm | 474 | 0.01 | 1.4e-03 | -8.49 | 6.7 | 1.5e-11 | -0.45 | 0.29 | 0.27 | FALSE |
33 | ROSMAP | Brain Pre-frontal Cortex | SMIM8 | 0.21 | 0.33 | enet | 34 | 0.38 | 3.9e-52 | 8.51 | -7.2 | 6.6e-13 | 0.81 | 0.32 | 0.68 | FALSE |
34 | ROSMAP | Brain Pre-frontal Cortex | SLC35A1 | 0.30 | 0.48 | enet | 25 | 0.50 | 5.7e-73 | 6.81 | 6.9 | 6.7e-12 | -0.64 | 1.00 | 0.00 | FALSE |
35 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | C6orf162 | 0.09 | 0.01 | enet | 12 | 0.03 | 2.5e-03 | -8.22 | 5.3 | 1.0e-07 | -0.31 | 0.26 | 0.13 | FALSE |
36 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C6orf164 | 0.06 | 0.05 | blup | 94 | 0.06 | 1.0e-11 | 8.99 | -8.1 | 5.9e-16 | 0.84 | 0.03 | 0.97 | FALSE |
37 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | C6orf164 | 0.07 | 0.06 | blup | 95 | 0.05 | 2.0e-03 | 8.50 | -8.7 | 4.1e-18 | 0.83 | 0.05 | 0.90 | FALSE |
38 | The Cancer Genome Atlas | Colon Adenocarcinoma | C6orf164 | 0.05 | 0.02 | enet | 8 | 0.02 | 1.9e-02 | 8.60 | -8.9 | 4.5e-19 | 0.89 | 0.02 | 0.72 | FALSE |
39 | The Cancer Genome Atlas | Esophageal Carcinoma | C6orf164 | 0.15 | 0.07 | enet | 10 | 0.04 | 1.7e-02 | -8.47 | -7.5 | 8.7e-14 | 0.65 | 0.04 | 0.66 | FALSE |
40 | The Cancer Genome Atlas | Glioblastoma Multiforme | C6orf162 | 0.16 | 0.08 | enet | 14 | 0.06 | 6.7e-03 | -8.16 | 6.5 | 1.0e-10 | -0.62 | 0.09 | 0.39 | FALSE |
41 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | C6orf163 | 0.06 | 0.04 | enet | 8 | 0.04 | 1.4e-05 | -8.62 | -6.2 | 5.4e-10 | 0.53 | 0.01 | 0.97 | FALSE |
42 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | C6orf164 | 0.06 | 0.08 | blup | 94 | 0.08 | 8.3e-09 | 8.60 | -8.1 | 4.6e-16 | 0.80 | 0.13 | 0.87 | FALSE |
43 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | SLC35A1 | 0.02 | 0.01 | blup | 72 | 0.00 | 8.7e-02 | 6.69 | -6.1 | 9.8e-10 | 0.60 | 0.02 | 0.84 | FALSE |
44 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | C6orf164 | 0.11 | 0.12 | blup | 95 | 0.14 | 5.0e-15 | 8.60 | -7.4 | 1.7e-13 | 0.78 | 0.24 | 0.76 | FALSE |
45 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | C6orf163 | 0.09 | 0.04 | enet | 6 | 0.09 | 1.4e-05 | -5.40 | -6.2 | 4.3e-10 | 0.45 | 0.04 | 0.71 | FALSE |
46 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | C6orf164 | 0.11 | 0.14 | enet | 8 | 0.12 | 1.6e-07 | 8.51 | -8.8 | 1.0e-18 | 0.88 | 0.08 | 0.92 | FALSE |
47 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C6orf162 | 0.05 | 0.03 | blup | 72 | 0.04 | 2.2e-05 | -8.15 | 6.6 | 4.2e-11 | -0.58 | 0.35 | 0.58 | FALSE |
48 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C6orf164 | 0.04 | 0.02 | blup | 95 | 0.04 | 5.4e-05 | -8.23 | -9.1 | 8.8e-20 | 0.84 | 0.23 | 0.77 | FALSE |
49 | The Cancer Genome Atlas | Brain Lower Grade Glioma | ZNF292 | 0.03 | 0.02 | lasso | 3 | 0.02 | 7.2e-04 | -4.38 | 7.5 | 5.9e-14 | -0.83 | 0.04 | 0.84 | FALSE |
50 | The Cancer Genome Atlas | Lung Adenocarcinoma | C6orf164 | 0.09 | 0.12 | blup | 95 | 0.11 | 4.1e-13 | 8.51 | -8.5 | 2.1e-17 | 0.86 | 0.08 | 0.92 | FALSE |
51 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | C6orf164 | 0.06 | 0.06 | lasso | 4 | 0.07 | 4.6e-08 | 8.50 | -8.1 | 3.9e-16 | 0.84 | 0.05 | 0.95 | FALSE |
52 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | C6orf163 | 0.06 | 0.02 | blup | 66 | 0.02 | 1.1e-02 | -8.22 | -8.9 | 6.9e-19 | 0.78 | 0.05 | 0.74 | FALSE |
53 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | C6orf164 | 0.12 | 0.12 | blup | 95 | 0.14 | 7.4e-10 | 7.83 | -8.4 | 6.2e-17 | 0.77 | 0.07 | 0.93 | FALSE |
54 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | SLC35A1 | 0.04 | 0.03 | lasso | 5 | 0.02 | 1.3e-02 | 6.81 | -7.1 | 1.6e-12 | 0.64 | 0.03 | 0.73 | FALSE |
55 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | C6orf164 | 0.07 | 0.11 | enet | 8 | 0.10 | 8.4e-05 | 8.55 | -8.8 | 1.3e-18 | 0.90 | 0.03 | 0.93 | FALSE |
56 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C6orf164 | 0.13 | 0.10 | blup | 95 | 0.11 | 1.5e-11 | 8.60 | -6.5 | 7.8e-11 | 0.59 | 0.28 | 0.72 | FALSE |
57 | The Cancer Genome Atlas | Stomach Adenocarcinoma | C6orf164 | 0.17 | 0.13 | lasso | 4 | 0.10 | 6.2e-08 | 8.55 | -8.0 | 9.3e-16 | 0.80 | 0.18 | 0.82 | FALSE |
58 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | C6orf164 | 0.12 | 0.08 | enet | 9 | 0.09 | 5.6e-04 | -3.32 | -6.8 | 8.5e-12 | 0.71 | 0.05 | 0.85 | FALSE |
59 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | SLC35A1 | 0.14 | 0.04 | blup | 72 | 0.07 | 1.4e-03 | 5.52 | -5.8 | 6.8e-09 | 0.52 | 0.01 | 0.83 | FALSE |
60 | The Cancer Genome Atlas | Thyroid Carcinoma | C6orf164 | 0.18 | 0.24 | lasso | 4 | 0.25 | 1.4e-24 | 8.51 | -8.6 | 6.3e-18 | 0.88 | 0.09 | 0.91 | FALSE |
61 | The Cancer Genome Atlas | Thyroid Carcinoma | SLC35A1 | 0.08 | 0.07 | enet | 17 | 0.07 | 5.0e-07 | 6.69 | 6.7 | 2.0e-11 | -0.59 | 0.01 | 0.99 | FALSE |
62 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | ORC3L | 0.20 | 0.00 | lasso | 8 | 0.00 | 2.6e-01 | -5.07 | 6.1 | 9.7e-10 | -0.53 | 0.01 | 0.25 | FALSE |